Correlation Between Anebulo Pharmaceuticals and CytoMed Therapeutics

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and CytoMed Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and CytoMed Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and CytoMed Therapeutics Limited, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and CytoMed Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of CytoMed Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and CytoMed Therapeutics.

Diversification Opportunities for Anebulo Pharmaceuticals and CytoMed Therapeutics

-0.2

Correlation Coefficient

Anebulo Pharmaceuticals  CytoMed Therapeutics

Good diversification

The 3 months correlation between Anebulo and CytoMed is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and CytoMed Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytoMed Therapeutics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with CytoMed Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytoMed Therapeutics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and CytoMed Therapeutics go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and CytoMed Therapeutics

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.39 times less return on investment than CytoMed Therapeutics. But when comparing it to its historical volatility, Anebulo Pharmaceuticals is 1.13 times less risky than CytoMed Therapeutics. It trades about 0.02 of its potential returns per unit of risk. CytoMed Therapeutics Limited is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  239.00  in CytoMed Therapeutics Limited on October 10, 2024 and sell it today you would lose (10.00) from holding CytoMed Therapeutics Limited or give up 4.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  CytoMed Therapeutics Limited

Anebulo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

CytoMed Therapeutics

Risk-Adjusted Performance

5 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CytoMed Therapeutics Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, CytoMed Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anebulo Pharmaceuticals and CytoMed Therapeutics

The main advantage of trading using opposite Anebulo Pharmaceuticals and CytoMed Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, CytoMed Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytoMed Therapeutics will offset losses from the drop in CytoMed Therapeutics' long position.

The idea behind Anebulo Pharmaceuticals and CytoMed Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.